Form 4: Alkermes VP Samuel Parisi Executes Stock Option Exercise

Alkermes plc VP of Finance Samuel Joseph Parisi exercised stock options and sold a portion of the resulting shares.

Summary

• Samuel Joseph Parisi, VP of Finance (Interim PAO) at Alkermes plc, exercised options for 16,217 ordinary shares on May 29, 2026.
• The exercise involved 3,392 shares at $20.03 and 12,825 shares at $19.34.
• Following the exercise, 16,217 shares were sold at a weighted average price of $42.3634 per share.
• The reporting person retains 7,717 ordinary shares following these transactions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents standard personal financial management by an executive rather than a strategic corporate shift.

Positives

• The transaction reflects the exercise of long-term incentive compensation (stock options) by a member of the finance leadership team.

Negatives

• The transaction resulted in a net reduction of the reporting person's direct beneficial ownership of company stock.

Risks

• None identified; this is a standard executive compensation-related transaction.

Future Outlook

Not applicable; this is a retrospective disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that executive stock option exercises are routine corporate events and generally do not signal a change in company strategy or fundamental outlook.

Comparison to Industry Standards

• The transaction aligns with standard executive equity management practices in the biopharmaceutical sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction size is relatively small compared to total outstanding shares.

Next Steps

• None

Key Dates

Keywords

Alkermes, ALKS, Insider Trading, Form 4, Stock Options, Executive Compensation